Echo Therapeutics (NASDAQ:ECTE): Current price $0.79
The firm reported that the United States Patent and Trademark Office has issued U.S. Patent No. 8,386,027, “Skin Permeation Device For Analyte Sensing or Transdermal Drug Delivery,” for its Prelude SkinPrep System, which is the skin permeation component of the Symphony CGM System. Echo Therapeutics is a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.